A potential target for Medicare Advantage reform may be plans' increasing reliance on step therapy for Part B-covered drugs, which has become increasingly burdensome on patients.

Enrollment in the new Medicare Prescription Payment Plan was lower than expected in the first year and well below CMS expectations, and invoicing data indicates members are slow to pay.